Samples of Our Collaboration

US Health

Our research, analytics, and advisory (RAA) services in U.S. health focus on four key areas: health economics and outcomes research (HEOR), health services research, program evaluation, and regulatory insights..

PEER-REVIEWED PUBLICATIONS 

Members of the core team collaborated in the following peer-reviewed publications.

  • Kovesdy C, Ebert N, Vizcaya D, Walsh M, Kosiborod M, Layton B, THAPA B, Curhan G, ……Farjat AE, Oberprieler N. Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the United States: A Cohort Study from the FOUNTAIN platform. Nephron. 2025 (Revised and Resubmitted, Awaiting Decision). 

  • Kalia H, THAPA B, Staats P, Martin P, Stetter K, Feldman B, Marci C. Real-World Healthcare Utilization and Costs of Peripheral Nerve Stimulation with a Micro-IPG System. Pain Management. 2025. 

  • Rahman M, THAPA BB, Santostefano C, et al. Patterns of Migration Following Dementia Diagnosis. JAMA Network Open. 2024. 

  • Kosar CM, THAPA BB, Muench U, et al. Nurse Practitioner Care, Scope of Practice, and End-of-Life Outcomes for Nursing Home Residents with Dementia. JAMA Health Forum. 2024. 

  • Zhang T, Santostefano CM, Harris D, Coe AB, Zullo AR, Gerlach LB, JOSHI R, Bynum JPW, Shireman TI. Effects of visitation restriction on antipsychotic drug use among nursing home residents with ADRD during the COVID-19 pandemic. JAMDA. 2024.

  • Zullo AR, Riester MR, Varma H, Daiello L, Gerlach LB, Coe AB, Thomas KS, JOSHI R, Zhang T, Shireman TI, Bynum JPW. Effects of Nursing Home Changes in Antipsychotic Use on Outcomes Among Residents with Dementia. Journal of the American Medical Directors Association (JAMDA). 2024.

  • Hayes KN, Cupp MA, JOSHI R, Riester MR, Beaudoin FL, Zullo AR. Differences in opioid prescriptions by race among U.S. older adults with a hip fracture transitioning to community care. Journal of the American Geriatrics Society (JAGS). 2024. 

  • Coe AB, Zhang T, Zullo AR, Gerlach LB, Daiello LA, Varma H, Lo D, JOSHI R, Bynum JPW, Shireman TI. Association of nursing home antipsychotic reduction policies with antipsychotic use in community dwellers with dementia. Journal of the American Geriatrics Society. 2024.

  • Shakya I, Zullo AR, Hayes KN, JOSHI R, Berry SD. Risk factors for urinary tract infections among nursing home residents initiating sodium-glucose cotransporter-2 inhibitors. Journal of the American Geriatrics Society (JAGS). 2024. 

  • Riester MR, Zullo AR, JOSHI R, Daiello LA, Hayes KN, Ko D, Kim DH, Munshi M, Berry SD. Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes. Diabetes, Obesity and Metabolism. 2024.

     

  • Riester MR, Beaudoin FL, JOSHI R, Hayes KN, Cupp MA, Berry SD, Zullo AR. Evaluation of post-acute care and one-year outcomes among Medicare beneficiaries with hip fractures: a retrospective cohort study. BMC Medicine. 2023.

  • *Cupp MA, Beaudoin F, Hayes KN, Riester M, Berry S, JOSHI R, Zullo AR. Post-Acute Care Setting after Hip Fracture Hospitalization and Subsequent Opioid Use in Older Adults. Journal of the American Medical Directors Association (JAMDA). 2023.

     

  • Zhang T, Thomas K, Zullo AR, Coe AB, Gerlach LB, Daiello L, Varma H, MS; Lo D, JOSHI R, Bynum JPW, Shireman TI. State Variation in Antipsychotic Use among Assisted Living Residents with Dementia. Journal of the American Medical Directors Association (JAMDA). 2023.

  • Oh, H., White, E., Muench, U., Santostefano, C., THAPA, B., Kosar, C., Gadbois, E., Osakwe, Z. T., Gozalo, P., & Rahman, M. Advanced Practice Clinician Care and End‐of‐Life Outcomes for Community‐and Nursing Home‐Dwelling Medicare Beneficiaries with Dementia. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2023.

  • THAPA, B. B., Li, X., & Galárraga, O. Impacts of Community‐Based Care Program on Health Care Utilization and Cost. The American Journal of Managed Care, 28(4), 187–191. 2022.

  • Coe AB, Zhang T, Zullo AR, Gerlach LB, Thomas KS, Daiello LA, Varma H, Lo D, JOSHI R, Shireman TI, Bynum JPW. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership. Journal of the American Geriatrics Society (JAGS). 2022.

  • THAPA, B. B., Laws, M. B., & Galárraga, O. Evaluating the Impact of Integrated Behavioral Health Intervention. Medicine. 2021. 

PEER-REVIEWED ABSTRACTS

Members of the core team collaborated in the following peer-reviewed abstracts.

  • Patient Characteristics, Disease Symptoms, and Treatment Patterns of Patients with Ulcerative Colitis and Crohn’s Disease from the United States: Results from a Retrospective, Longitudinal Study. Digestive Disease Week. (2025).

     

  • Generalized Pustular Psoriasis Patient Characteristics and Treatments in the United States. Society for Investigative Dermatology (SID). 2024.

     

  • Description of Real-World Healthcare Resource Utilization and Costs Among Patients Receiving Long-Term Peripheral Nerve Stimulation Therapy from a Micro-IPG System. The American Society of Interventional Pain Physicians (ASIPP). 2024.

     

  • Long-Term Peripheral Nerve Stimulation Therapy from a Micro-IPG System Is Associated with Reduction of Healthcare Resource Utilization and Related Costs – Preliminary Data. The American Society of Pain and Neuroscience. 2024.

     

  • Effects of involuntary job loss on health outcomes: Evidence from health and retirement study in the US. AcademyHealth Annual Conference. 2020.

     

  • Evaluating the effects of integrated behavioral health intervention: Evidence from Rhode island. American Society of Health Economists (ASHECON) Annual Conference. 2020.

     

  • Clinical Outcomes in US Patients Initiating Finerenone – A Report from the FOUNTAIN Platform. European Renal Association (ERA). 2024.

     

  • Clinical Outcomes in US Patients Initiating Finerenone – A Report from the FOUNTAIN Platform. Annual Conference of the Association of Diabetes Care and Education Specialists (ADCES). 2024.

     

  • Reduction in UACR in People with CKD and T2D Initiating Finerenone: A Comedication Subgroup Analysis from the FOUNTAIN Platform. The American Society of Nephrology. 2024.

     

  • Reduction in UACR in People with CKD and T2D Initiating Finerenone: A CKD Stage Subgroup Analysis from the FOUNTAIN Platform. The American Society of Nephrology. 2024.

     

  • Opioid use after hip fracture and one-year risk of subsequent fracture: a self-controlled case series analysis. Society for Epidemiologic Research Conference. 2023.

     

  • Incidence of SGLT2I medication adverse events among older adults with multimorbidity. Society for Epidemiologic Research Conference. 2023.

     

  • Characterizing Internal Migration Among Individuals Diagnosed with Dementia. World Congress on Health Economics. 2023.

     

  • Post-Acute Care Setting after Hip Fracture Hospitalization and Subsequent Opioid Use in Older Adults. Abstract selected for oral presentation. ISPE Mid-Year Meeting. 2023.

     

  • One-year opioid use following discharge from post-acute care after hip fracture. International Conference in Pharmacoepidemiology and Therapeutic Risk Management. 2022.

     

  • Differences in opioid use after hip fracture by race and post-acute care use among U.S. older adults. International Conference in Pharmacoepidemiology and Therapeutic Risk Management. 2022.

     

  •  Nurse Practitioner Care, Scope of Practice Regulations, and End‐of‐Life Care for Nursing Home Residents with Dementia. American Society of Health Economists. 2022.

     

  • Nurse Practitioner Care, Scope of Practice Regulations, and End‐of‐Life Care for Nursing Home Residents with Dementia. AcademyHealth Annual Conference. 2022.

     

  • Evaluating the effects of integrated behavioral health intervention: Evidence from Rhode Island. AcademyHealth Annual Conference. 2020.

     

  • Does higher hospital competition mean increased quality of care? AcademyHealth Annual Conference. 2019